BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6116595)

  • 1. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Somatostatin-like immunoreactivity in chemically sympathectomized dogs.
    Schusdziarra V; Rouiller D; Harris V; Dey R; Unger RH
    Horm Metab Res; 1980 Dec; 12(12):656-60. PubMed ID: 6110628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of meal.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Regul Pept; 1981 Feb; 1(5):353-63. PubMed ID: 7255767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of somatostatin-like immunoreactivity from the lower gut.
    Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal.
    Schusdziarra V; Rouiller D; Pietri A; Harris V; Zyznar E; Conlon JM; Unger RH
    Am J Physiol; 1979 Dec; 237(6):E555-60. PubMed ID: 517653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma free fatty acid levels contribute to the hypersomatostatinemia of insulin deficiency.
    Wasada T; Howard B; McCorkle K; Harris V; Unger RH
    Diabetes; 1981 Apr; 30(4):358-61. PubMed ID: 6110603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo study of glucose-induced somatostatin secretion: comparison in normal and alloxan-diabetic dogs.
    Ribes G; Gross R; Chenon D; Puech R; Loubatieres-Mariani MM
    Pancreas; 1987; 2(6):638-44. PubMed ID: 2894026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
    Schusdziarra V; Harris V; Unger R
    Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acetylcholine on the release of pancreatic and gastric somatostatin-like immunoreactivity in normal, chemically sympathectomized and indomethacin-treated dogs.
    Schusdziarra V; Stapelfeldt W; Klier M; Pfeiffer EF
    Hepatogastroenterology; 1982 Aug; 29(4):153-6. PubMed ID: 6127302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
    Ahrén B; Veith RC; Paquette TL; Taborsky GJ
    Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of plasma somatostatin-like immunoreactivity to nutrients in normal and alloxan diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Conlon JM; Unger RH
    Endocrinology; 1978 Dec; 103(6):2264-73. PubMed ID: 748047
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.